Nirmatrelvir-ritonavir, sold by Pfizer under the name Paxlovid, is commonly prescribed to treat COVID-19. When treating some heart patients, however, physicians may want to consider an alternative approach.
Claire Ernst, director of government affairs for the Medical Group Management Association, talked to us about why extending the federal COVID-19 health emergency was so important for healthcare providers.
Hospitals have been nationally ranked by popular media sources such as U.S. World News & Report for decades, but the quality measures used to determine these lists may be missing one key domain––health equity.
The 2022-2023 flu season is off to an early start, according to the Centers for Disease Control and Prevention (CDC), which noted there are increases happening in most of the country despite relatively low activity overall.
Connie Lehman, MD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at Massachusetts General Hospital, discusses how artificial intelligence (AI) is being implemented in breast imaging.
Left, HeartFlow's RoadMap AI analysis enables cardiac CT readers to identify stenoses in the major coronary arteries. The AI provides visualization and quantification of the location and severity of anatomic narrowings. Right image, HeartFlow's Plaque analysis AI algorithm automates assessment of coronary plaque characteristics and volume on CCTA exams to greatly reduce the time it takes to manually assess and quantify these features.
The solutions, Plaque Analysis and RoadMap Analysis, both use coronary CT angiography to provide clinicians with a noninvasive look at patients who present with coronary artery disease and face a heightened myocardial infarction risk.
